AbbVie Healthcare India found guilty of unethical marketing practices, violating UCPMP 2024, facing tax liability and ...
This week, the department of pharmaceuticals (DoP) said the Indian arm of US firm AbbVie violated the newly amended Uniform Code for Pharmaceutical Marketing Practices. What did AbbVie do, and ...
The Department of Pharmaceuticals (DoP) has found AbbVie Healthcare India in violation of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP). The company allegedly spent over Rs 1.91 ...
The Apex Committee for Pharma Marketing Practices found Abbvie in breach of the UCPMP, by sponsoring foreign vacations to Monaco and Paris of about 30 healthcare practitioners | Photo Credit ...
Jan 15 (Reuters) - AbbVie (ABBV.N), opens new tab plans to "commit less capital" towards experimental medicines for psychiatric disease, CEO Robert Michael said at an industry conference on ...
AbbVie is scheduled to report fourth-quarter earnings on Jan ... US IPO 12:45 PM UTC · Updated ago Energycategory Oil jumps ...
What is the case against AbbVie India? In May 2024, the DoP received an anonymous complaint alleging AbbVie Healthcare India flew 30 doctors—experts in Botox and Juvederm—to Paris and Monaco.
In a move to curb unethical promotional practices in the pharma sector after the introduction of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), the Apex Committee for Pharma ...